Case Study: AstraZeneca cuts costs and boosts productivity with Reltio

AstraZeneca streamlined tech landscape to boost productivity

AstraZeneca, a global life sciences company, was struggling with 67 legacy MDM deployments across more than 140 countries. The fragmented environment created high infrastructure and management costs, slow sales processes, poor data visibility, and difficult-to-manage on-premise systems. To address these challenges, AstraZeneca turned to Reltio for a modern master data management platform.

Reltio replaced AstraZeneca’s 67 legacy MDM systems with 3 interlinked regional hubs and integrated with marketing tools, consent management, and sales systems. The result was £3.6 million in annual MDM cost savings, a 10x boost in sales rep productivity, and a live patient master in just 14 weeks. Reltio also helped AstraZeneca improve customer communications, centralize consent management, and reduce compliance risk.

AstraZeneca

Joanna Walker

Global MDM Architect